Jim Simons's top holdings (April 2025) include Palantir Technologies Inc (PLTR), a company specializing in data analytics and software platforms.

Jim Simons is the founder of Renaissance Technologies, a quantitative investment management firm. The firm utilizes mathematical and statistical methods to develop and implement its investment strategies. Renaissance Technologies is known for its data-driven approach to trading across various financial markets.

Palantir Technologies Inc (PLTR)

Palantir Technologies focuses on building and deploying software platforms for data analysis. These platforms are utilized by organizations across various sectors to manage and interpret large, complex datasets. Palantir's Gotham platform is geared towards government and intelligence agencies, while its Foundry platform serves commercial clients. Palantir Technologies has a market capitalization of $201.35B, with Jim Simons's position currently valued at $1.93B. Analysts have set a price target of $84.8 for Palantir. The company's discounted cash flow analysis suggests a value of $3.63 per share.

Here's an overview of Jim Simons's trades in Palantir Technologies Inc:

Verisign Inc. (VRSN)

Verisign is a global leader in domain name registry services and internet infrastructure. The company operates the .com and .net top-level domains, ensuring the stability and security of these critical internet resources. Verisign also provides various security services, including DDoS mitigation and DNSSEC deployment. Verisign has a market capitalization of $23.74B, while the current value of Jim Simons's holding is $743.34M. The company's discounted cash flow analysis suggests a value of $192.8 per share. Analysts have set a price target of $250.0 for Verisign.

Here's an overview of Jim Simons's trades in Verisign Inc.:

Sprouts Farmers Market Inc (SFM)

Sprouts Farmers Market is a grocery retailer focused on offering fresh, natural, and organic products. The company operates a chain of stores that emphasize produce, bulk foods, vitamins, and supplements. Sprouts aims to provide a healthy and affordable shopping experience for its customers. Sprouts Farmers Market has a market capitalization of $14.57B, with Jim Simons's position currently valued at $693.14M. The company's discounted cash flow analysis suggests a value of $58.05 per share.

Here's an overview of Jim Simons's trades in Sprouts Farmers Market Inc:

Vertex Pharmaceuticals, Inc. (VRTX)

Vertex Pharmaceuticals is a biotechnology company focused on developing and commercializing therapies for serious diseases. Their primary focus is on cystic fibrosis (CF), where they have developed multiple approved treatments. Vertex is also expanding its research and development efforts to other areas, including pain, alpha-1 antitrypsin deficiency, and APOL1-mediated kidney diseases. Vertex Pharmaceuticals' market cap stands at $126.52B, while the current value of Jim Simons's holding is $677.28M. The analyst price target for Vertex Pharmaceuticals is $482.2. The company's discounted cash flow analysis suggests a value of $605.8 per share.

Here's an overview of Jim Simons's trades in Vertex Pharmaceuticals, Inc.:

United Therapeutics Corp (UTHR)

United Therapeutics Corporation focuses on the development and commercialization of innovative therapies to address the unmet medical needs of patients with chronic and life-threatening diseases. The company's primary area of focus is pulmonary hypertension, for which it offers a range of approved therapies. United Therapeutics is also involved in research and development programs related to other diseases, including cancer and fibrotic conditions. The company's market cap stands at $13.79B, with Jim Simons's position currently valued at $641.19M. The company's discounted cash flow analysis suggests a value of $875.47 per share.

Here's an overview of Jim Simons's trades in United Therapeutics Corp: